Cardinal Health (NYSE:CAH) Given New $215.00 Price Target at JPMorgan Chase & Co.

Key Points

• JPMorgan cut its price target on Cardinal Health to $215 from $243 and kept a "neutral" rating, implying roughly a 9.16% upside from the stock's current price.
• Analyst consensus remains more positive overall: the stock has a "Moderate Buy" average rating with a consensus price target of $241.80, and several firms have issued higher targets (up to $275) and "Buy"/"Outperform" ratings.
• In the latest quarter Cardinal Health beat EPS expectations ($3.17 vs. $2.79) but missed revenue forecasts, set FY2026 guidance of 10.70–10.80 EPS (consensus 10.76), and reported a low net margin (0.62%) with a negative ROE (‑92.61%).

Cardinal Health (NYSE:CAH - Get Free Report) had its price target lowered by research analysts at JPMorgan Chase & Co. from $243.00 to $215.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 9.16% from the company's current price.

Other research analysts also recently issued research reports about the stock. Mizuho lifted their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an "outperform" rating in a research note on Friday, February 6th. Jefferies Financial Group lifted their price target on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a "buy" rating in a research note on Thursday, January 22nd. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a research note on Friday. Finally, Leerink Partners reiterated an "outperform" rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $241.80.

Cardinal Health Price Performance

Shares of CAH stock traded up $1.72 during trading on Monday, reaching $196.96. The company's stock had a trading volume of 2,239,969 shares, compared to its average volume of 1,767,692. The company has a market capitalization of $46.35 billion, a price-to-earnings ratio of 30.12, a P/E/G ratio of 1.16 and a beta of 0.53. The stock's 50-day moving average price is $213.73 and its 200 day moving average price is $206.18. Cardinal Health has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analysts' expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business's quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health will post 10.76 EPS for the current fiscal year.

Institutional Trading of Cardinal Health

Several institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Cardinal Health by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company's stock worth $6,461,179,000 after buying an additional 617,775 shares during the last quarter. State Street Corp lifted its position in shares of Cardinal Health by 1.8% during the 4th quarter. State Street Corp now owns 12,509,230 shares of the company's stock worth $2,570,647,000 after buying an additional 221,497 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company's stock worth $1,336,750,000 after buying an additional 43,924 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock worth $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Cardinal Health in the 4th quarter valued at $790,344,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.